Mednet Logo

What is your preferred TKI and dosing for AYAs or adult patients with Ph+ ALL?

NCCN does not list any preferences for the TKIs in their guidelines.
1 Answer
Mednet Member
Mednet Member
Medical Oncology · Novant Cancer Institute
Answered on

We typically follow the MD Anderson updated approach of adding dasatinib 100mg daily for first 2 weeks in cycle 1 and then 70mg daily starting cycle 2 (Cancer 2015; 121:4158).

How long to continue? That’s a tough one with essentially no mature data. The COG study continued for only 2 years, though da...

Join for free or sign in to see the full answer